End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.19 CNY | +1.35% | +3.02% | -7.35% |
04-24 | Fosun Pharma Unit Gets Marketing Registration Approval for Tuberculosis Drug from Chinese Regulator | MT |
04-18 | China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 600196 Stock
- Revisions Shanghai Fosun Pharmaceutical (Group) Co., Ltd.